Palantir's Growth Has Kept Accelerating, but Can the Rally Continue?

Palantir reported Q2 revenue growth of 93%, including 149% year-over-year growth in U.S. commercial revenue to $764 million and 90% growth in U.S. government revenue to $809 million, but Wall Street expects growth to decelerate to 84% in Q3. Its U.S. commercial customer base rose 6% sequentially to 653, a slowing pace that could pressure future top-line acceleration. Despite a 55% profit margin, the stock trades near 150x trailing earnings; earnings would need to rise more than 250% for its P/E to decline to 40x at the current share price, leaving valuation risk if growth moderates.

Analysis

The relevant inflection is not reported revenue growth but whether incremental revenue remains dominated by existing accounts. A decelerating logo-addition rate can be benign if expansion revenue, net-dollar retention, and large-deal conversion remain strong; it becomes material if commercial bookings and remaining performance obligations slow simultaneously. The market is likely to punish even a modest deceleration because PLTR’s valuation leaves little room for a transition from AI-platform scarcity to a more conventional enterprise-software sales cycle.

Near-term, the key catalyst is the next guide rather than the reported quarter: upside needs to be accompanied by a forward outlook that demonstrates sustained deal velocity, not merely revenue recognition from prior contracts. Over 1-3 months, watch U.S. commercial customer additions, average revenue per customer, RPO/bookings, and stock-based-compensation dilution; a miss in any two would support multiple compression. The 6-18 month upside case remains credible if Palantir proves that deployment can scale internationally and converts pilots into recurring enterprise-wide commitments, but that requires evidence beyond a small number of large U.S. accounts.

Consensus bearishness based solely on headline P/E may be incomplete: high incremental margins mean earnings can compound faster than revenue if sales efficiency holds. Conversely, this is precisely why valuation risk is asymmetric—there is limited margin-expansion cushion if growth normalizes, while peers with lower expectations can rerate on similar AI demand. Treat promotional commentary and analyst estimates as low-signal until bookings, retention, and customer concentration data independently validate the growth path.

Key Decisions for Investors

• Do not initiate a directional cash short solely on valuation. Establish a 1-3 month PLTR watch: consider a defined-risk put spread only if post-results guidance or bookings decelerate while the shares hold or rally; use a strike structure with maximum loss limited to premium because upside-surprise risk remains substantial.
• For AI exposure, consider a relative-value position: short PLTR against long NVDA in equal beta-adjusted dollar terms over the next earnings cycle. The thesis is that PLTR is more exposed to enterprise-budget and multiple risk, while NVDA retains broader infrastructure demand; exit if PLTR demonstrates reaccelerating customer additions and forward bookings.
• Require confirmation before adding long exposure: U.S. commercial net adds, RPO/bookings growth, and management guidance should each remain consistent with sustained high growth. If only revenue beats through deal expansion, regard a rally as an opportunity to reduce exposure rather than chase.
• Set a risk trigger on the relative trade: cover the PLTR short leg if it outperforms NVDA by 15% after earnings alongside improved forward guidance, since that would indicate the market is rewarding durable demand rather than a one-quarter beat.